Catalyst Wire Dossier Catalyst Wire Dossier

Levalbuterol Tartrate HFA Inhalation Aerosol MDI

levalbuterol tartrate · Sumitomo Pharma America, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levalbuterol Tartrate HFA Inhalation Aerosol MDI, covering 2016-02-03 to 2016-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects [Phase 3]

See pricing